Because of the absence of the major substrate of CD45, LCK, it is plausible that in ALK+ ALCL the CD45 phosphatase activity affects the JAK/STAT pathway therefore playing a role as a tumor suppressor. The gene discussed is ALK; the disease is neoplasm.